Association of Polymorphic Markers of the TP53, MDM2, and CDKN1A Genes with the Risk of Ovarian Cancer

被引：0
|
作者：
P. K. Brenner
M. A. Kapralova
D. S. Khodyrev
S. V. Khokhlova
G. N. Khabas
A. V. Asaturova
Yu. V. Nosova
L. N. Kayumova
T. M. Zavarykina
机构：
[1] Emanuel Institute of Biochemical Physics,
[2] Russian Academy of Sciences,undefined
[3] Federal Scientific and Clinical Center of Specialized Types of Medical Care and Medical Technologies of the Federal Medical and Biological Agency of the Russian Federation,undefined
[4] Kulakov National Medical Research Center of Obstetrics,undefined
[5] Gynecology and Perinatology,undefined
[6] Sechenov First Moscow State Medical University (Sechenov University),undefined
来源：
Russian Journal of Genetics | 2022年 / 58卷
关键词：
ovarian cancer; polymorphic marker; cell cycle control; apoptosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1154 / 1158
页数：4
相关论文
共 50 条
  • [1] Association of Polymorphic Markers of the TP53, MDM2, and CDKN1A Genes with the Risk of Ovarian Cancer
    Brenner, P. K.
    Kapralova, M. A.
    Khodyrev, D. S.
    Khokhlova, S., V
    Khabas, G. N.
    Asaturova, A., V
    Nosova, Yu, V
    Kayumova, L. N.
    Zavarykina, T. M.
    RUSSIAN JOURNAL OF GENETICS, 2022, 58 (09) : 1154 - 1158
  • [2] Association of Molecular Genetic Markers of TP53, MDM2, and CDKN1A Genes with Progression-Free Survival of Patients with Ovarian Cancer after Platinum-Based Chemotherapy
    Zavarykina, T. M.
    Tyulyandina, A. S.
    Khokhlova, S. V.
    Khabas, G. N.
    Asaturova, A. V.
    Nosova, Yu. A.
    Brenner, P. K.
    Kapralova, M. A.
    Atkarskaya, M. V.
    Khodyrev, D. S.
    Burdennyi, A. M.
    Loginov, V. I.
    Stenina, M. B.
    Sukhikh, G. T.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2020, 169 (04) : 486 - 490
  • [3] Association of Molecular Genetic Markers of TP53, MDM2, and CDKN1A Genes with Progression-Free Survival of Patients with Ovarian Cancer after Platinum-Based Chemotherapy
    T. M. Zavarykina
    A. S. Tyulyandina
    S. V. Khokhlova
    G. N. Khabas
    A. V. Asaturova
    Yu. A. Nosova
    P. K. Brenner
    M. A. Kapralova
    M. V. Atkarskaya
    D. S. Khodyrev
    A. M. Burdennyi
    V. I. Loginov
    M. B. Stenina
    G. T. Sukhikh
    Bulletin of Experimental Biology and Medicine, 2020, 169 : 486 - 490
  • [4] Association between polymorphisms in TP53 and MDM2 genes and susceptibility to prostate cancer
    Hashemi, Mohammad
    Amininia, Shadi
    Ebrahimi, Mahboubeh
    Simforoosh, Nasser
    Basiri, Abbas
    Ziaee, Seyed Amir Mohsen
    Narouie, Behzad
    Sotoudeh, Mehdi
    Mollakouchekian, Mohammad Javad
    Maleki, Esmaeil Rezghi
    Hanafi-Bojd, Hamideh
    Rezaei, Maryam
    Bahari, Gholamreza
    Taheri, Mohsen
    Ghavami, Saeid
    ONCOLOGY LETTERS, 2017, 13 (04) : 2483 - 2489
  • [5] Association between polymorphisms of TP53 and MDM2 and prostate cancer risk in southern Chinese
    Bin Xu
    Xu, Zheng
    Cheng, Gong
    Min, Zhi-Chao
    Mi, Yuanyuan
    Zhang, Zhi-zhong
    Tao, Jun
    Li, Peng-Chao
    Wang, Mei-Lin
    Tang, Jia-Lin
    Zhang, Zheng-Dong
    Zhang, Wei
    Wu, Hong-Fei
    Feng, Ning-Han
    Hua, Li-Xin
    CANCER GENETICS AND CYTOGENETICS, 2010, 202 (02) : 76 - 81
  • [6] Analysis of MDM2 and TP53 genes in canine liposarcoma
    Muscatello, Luisa Vera
    de Biase, Dario
    Maloberti, Thais
    di Oto, Enrico
    Tallini, Giovanni
    Pellegrino, Valeria
    Bacci, Barbara
    Roccabianca, Paola
    Lepri, Elvio
    Crippa, Luca
    Avallone, Giancarlo
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [7] Cross talk between TP53, MDM2 and CDKN1A expression and progression-free survival in patients with ovarian cancer after platinum-based chemotherapy
    Asaturova, A.
    Zavarikina, T.
    Tyulandina, A.
    Hohlova, S.
    Nosova, J.
    Khabas, G.
    Burdenny, A.
    Kapralova, M.
    Loginov, V.
    Brenner, P.
    Atkarskaya, M.
    Hodirev, D.
    VIRCHOWS ARCHIV, 2020, 477 : S58 - S59
  • [8] TP53 and MDM2 polymorphisms and the risk of endometrial cancer in postmenopausal women
    Zajac, Agnieszka
    Smolarz, Beata
    Stachowiak, Grzegorz
    Wilczynski, Jacek R.
    MEDICAL ONCOLOGY, 2014, 31 (11) : 1 - 6
  • [9] TP53 and MDM2 polymorphisms and the risk of endometrial cancer in postmenopausal women
    Agnieszka Zając
    Beata Smolarz
    Grzegorz Stachowiak
    Jacek R. Wilczyński
    Medical Oncology, 2014, 31
  • [10] The role of TP53 and MDM2 polymorphisms in TP53 mutagenesis and risk of non-melanoma skin cancer
    Almquist, Lindsay M.
    Karagas, Margaret R.
    Christensen, Brock C.
    Welsh, Marleen M.
    Perry, Ann E.
    Storm, Craig A.
    Nelson, Heather H.
    CARCINOGENESIS, 2011, 32 (03) : 327 - 330
12345